SNN
Smith & Nephew SNATS Inc
NYSE: SNN · HEALTHCARE · MEDICAL DEVICES
$30.38
-2.25% today
Updated 2026-04-29
Market cap
$12.97B
P/E ratio
21.24
P/S ratio
2.10x
EPS (TTM)
$1.43
Dividend yield
2.57%
52W range
$27 – $38
Volume
0.9M
Smith & Nephew SNATS Inc (SNN) Financial statements
SEC filings — annual and quarterly data.
Profit margin
10.10%
Operating margin
14.00%
ROE
11.80%
ROA
5.27%
Debt/equity
0.62x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $2.78B | $745.00M | 72.33% | 19.32% | 26.81% |
| 2007 | $3.37B | $316.00M | 70.50% | 14.63% | 9.38% |
| 2008 | $3.80B | $377.00M | 71.67% | 16.57% | 9.92% |
| 2009 | $3.77B | $472.00M | 72.69% | 19.17% | 12.51% |
| 2010 | $3.96B | $615.00M | 73.98% | 23.22% | 15.52% |
| 2011 | $4.27B | $582.00M | 73.30% | 20.19% | 13.63% |
| 2012 | $4.14B | $729.00M | 74.14% | 20.45% | 17.62% |
| 2013 | $4.35B | $556.00M | 74.72% | 18.62% | 12.78% |
| 2014 | $4.62B | $501.00M | 74.83% | 16.22% | 10.85% |
| 2015 | $4.63B | $410.00M | 75.33% | 13.55% | 8.85% |
| 2016 | $4.67B | $784.00M | 72.76% | 17.16% | 16.79% |
| 2017 | $4.76B | $767.00M | 73.81% | 19.60% | 16.10% |
| 2018 | $4.90B | $663.00M | 73.53% | 17.60% | 13.52% |
| 2019 | $5.14B | $600.00M | 73.96% | 15.86% | 11.68% |
| 2020 | $4.56B | $448.00M | 69.39% | 6.47% | 9.82% |
| 2021 | $5.21B | $524.00M | 70.40% | 11.38% | 10.05% |
| 2022 | $5.21B | $223.00M | 70.47% | 6.04% | 4.28% |
| 2023 | $5.55B | $263.00M | 68.82% | 7.66% | 4.74% |
| 2024 | $5.81B | $412.00M | 69.64% | 11.31% | 7.09% |
| 2025 | $6.18B | $626.46M | 68.01% | 16.27% | 10.14% |